Edward Gershburg
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$2.8MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 13, 2026 | NIH | SBIR Phase II Preclinical Evaluation of a Novel Immunomodulatory Vaccine for Preventing and Treating HSV Infections | $999K | Rational Vaccines, Inc. |
| Jan 24, 2025 | NIH | SBIR Phase II Preclinical Evaluation of a Novel Immunomodulatory Vaccine for Preventing and Treating HSV Infections | $987K | Rational Vaccines, Inc. |
| Aug 3, 2023 | NIH | SBIR Phase II Preclinical Evaluation of a Novel Immunomodulatory Vaccine for Preventing and Treating HSV Infections | $288K | Rational Vaccines, Inc. |
| Aug 1, 2023 | NIH | SBIR Phase I Development of a Highly Specific and Sensitive HSV-1 and HSV-2 Diagnostic Test | $291K | Rational Vaccines, Inc. |
| Aug 31, 2022 | NIH | SBIR Phase I A novel prophylactic and therapeutic vaccine for ocular herpes simplex virus infections | $270K | Rational Vaccines, Inc. |
Peer ranks
Federal funding#746
Awards as PI#470
Patents#505
Companies
- Rational Vaccines, Inc.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.